Full Text View
Tabular View
No Study Results Posted
Related Studies
A Long-Term Safety Study of Once-Daily Travatan
This study is ongoing, but not recruiting participants.
First Received: January 3, 2003   Last Updated: August 4, 2008   History of Changes
Sponsored by: Alcon Research
Information provided by: Alcon Research
ClinicalTrials.gov Identifier: NCT00051168
  Purpose

Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.


Condition Intervention Phase
Glaucoma, Open-Angle
Ocular Hypertension
Drug: Travoprost (0.004%)
Phase III

Genetics Home Reference related topics: early-onset glaucoma
MedlinePlus related topics: Glaucoma High Blood Pressure
Drug Information available for: Travoprost
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: A Long-Term Safety Study of Once-Daily TRAVATAN

Further study details as provided by Alcon Research:

Study Start Date: January 2006
Estimated Study Completion Date: April 2009
Estimated Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Adult patients of any race and either sex with chronic angle-closure glaucoma.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00051168

Locations
United States, Texas
Europe
Fort Worth, Texas, United States
Sponsors and Collaborators
Alcon Research
  More Information

No publications provided

Study ID Numbers: C-02-20
Study First Received: January 3, 2003
Last Updated: August 4, 2008
ClinicalTrials.gov Identifier: NCT00051168     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Alcon Research:
Glaucoma
POAG
OAG
OHT

Study placed in the following topic categories:
Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Travoprost
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:
Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Cardiovascular Diseases
Ocular Hypertension
Hypertension

ClinicalTrials.gov processed this record on May 07, 2009